- Home
- » Useful Info
- » Vets
- » Guidance
- » Antimicrobial Resistance
Antimicrobial Resistance
Antimicrobial resistance is an emerging clinical problem that is recognised internationally as one of the largest threats to human and animal health. All major health and veterinary organisations are working to try and limit the development of resistance so that effective antimicrobials can be retained for use in clinical practice. BEVA believes that effective self-regulation on the responsible use of antimicrobials is a more suitable option than a legislative solution. The new toolkit is modelled on BSAVA PROTECT guidelines developed by SAMSoc, but incorporating the essential watchwords ‘Monitor’ and ‘Educate’. The toolkit enables veterinary surgeons to:
If you choose to you may submit your document to the BEVA office. This will enable BEVA to improve their documents for the future. All data submitted to BEVA will be treated in the strictest confidence and details of originating practices will not be used in any way. If you have any comments to improve these policy documents please email. The Toolkit
- Standardise dosing frequency and dose rates across the practice, to optimise antimicrobial effectiveness using the BEVA antimicrobial policy template 2012 as an example (see guidelines for use of PDF forms below). Sometimes dosing intervals licenced in the marketing authorisation differ from current clinical evidence. Members are encouraged to review the veterinary literature to determine these a collection of helpful articles can be found here. To access full text of EVJ and EVE articles you should login to the Members Area of the BEVA website first by clicking here.
- Classify antimicrobials of critical importance as PROTECTED. This should include the 3rd and 4th Generation cephalosporins (eg Ceftiofur and cefquinome) and fluoroquinolones (eg enrofloxacin) as well as the Macrolides (eg Azithromycin). These drugs should not be used empirically without culture and sensitivity testing, with some exceptions where best evidence supports their use (eq the treatment of Rhodococcus equi in the foal). AVOIDED antimicrobials are defined as those which should not be used within your practice and include vancomycin, non-ocular chloramphenicol and the carbapenems. Educate your staff to ensure that no orders are placed for drugs in this category.
- Formulate a policy whereby PROTECTED antimicrobials can be used with certain safeguards using the BEVA Use of protected antimicrobials policy document as an example.
- Formulate a policy to record the use of protected antimicrobials in your practice using the BEVA recording of protected antimicrobials document as an example.
- Identify common clinical presentations and suggest first line and alternative drugs for empirical treatment of these conditions using the BEVA antimicrobial policy template 2012 document as an example. Guidance on empirical and prophylactic antimicrobial use can be found here. To access full text of EVJ and EVE articles you should login to the Memebers Area of the BEVA website first by clicking here. Remember that the example document is by no means presented as the ‘ideal antimicrobial policy’. It is an example that you can change and amend as appropriate. Where members choose to, they may share their own version of this document with BEVA via the submit button in the hope that consensus can be achieved for a least some of these clinical conditions.
- Develop protocols to use Prophylactic antimicrobials in a variety of clinical conditions using the BEVA antimicrobial policy template 2012 as an example
- Formulate a policy to review antimicrobial susceptibility from any cultures obtained within the practice are using the BEVA review mechanisms document, and BEVA review mechanism form as examples. Audit emerging antimicrobial resistance and consider adapting guidelines for empirical use.
- BEVA has compiled a list of Frequently Asked Questions as an aid.
If you choose to you may submit your document to the BEVA office. This will enable BEVA to improve their documents for the future. All data submitted to BEVA will be treated in the strictest confidence and details of originating practices will not be used in any way. If you have any comments to improve these policy documents please email. The Toolkit



